Topics
Glioblastoma | Etiopathogenesis | Progression
Home > Publications > Topics > Glioblastoma > Etiopathogenesis > Progression
Wang S, Gu S, Chen J, Yuan Z, Liang P, Cui H.
Mechanism
of Notch Signaling Pathway in Malignant Progression of
Glioblastoma and Targeted Therapy.
Biomolecules.
2024 Apr 15;14(4):480. doi:
10.3390/biom14040480. PMID:
38672496.
Review.
ˍ
Mohamed AH, Obeid RA, Fadhil AA, Amir AA, Adhab ZH, Jabouri EA,
Ahmad I, Alshahrani MY.
BTLA and HVEM:
Emerging players in the tumor microenvironment and cancer
progression.
Cytokine.
2023 Oct 28;172:156412. doi:
10.1016/j.cyto.2023.156412. PMID:
39492110. Review˰ ˍ
Li J, Wu W, Ye L, Zheng B.
Hyperglycemia
as driver of glioblastoma progression: Insights from Mendelian
randomization and single-cell transcriptomics.
Brain
Res. 2025 Apr 8;1858:149636. doi:
10.1016/j.brainres.2025.149636. PMID:
40210146. Laboratory investigation˰
ˍ
Xia P.
The significance of
epithelial-mesenchymal transition (EMT) in the initiation,
plasticity, and treatment of glioblastoma.
Genes
Dis. 2025 Jun 6;13(1):101711. doi:
10.1016/j.gendis.2025.101711. PMID:
41141394. Review. ˍ